【レポートの概要（一部）】
★目次PDFファイル⇒http://h-and-i.main.jp/market-report/Vaczine/VAMV054_TOC.pdf
[Contents – Summary presentation (MS PowerPoint based)]
PAGES: 62 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form
Author’s note
Executive Summary
Commercial model key outputs
Herpes zoster vaccines: forecast revenues ($m) to 2030 (HI)
Herpes zoster vaccines: forecast volume (000 doses) to 2030 (HI)
Herpes zoster vaccines: volume (000s doses) and revenue ($m) by population to 2030 (HI)
Herpes zoster vaccines: volume (000s doses) by population and vaccine to 2030 (HI)
Herpes zoster vaccines: volume (000s doses) and revenue ($m) by country to 2030 (HI)
Herpes zoster vaccines: market share volume and revenue by country to 2030 (HI)
Herpes zoster vaccines: forecast revenues ($m) to 2030 (scenarios)
Commercial model key inputs
Age ranges/countries modelled
Existing vaccinees and penetration
Vaccine pricing
Market share – competitor zoster vaccines
Public/private split
Other model considerations
Varicella-zoster virus and herpes zoster (shingles): disease background
Varicella-zoster virus
Varicella-zoster virus – transmission and manifestations
Herpes zoster (shingles)
Presentation and symptoms of herpes zoster
Course of herpes zoster.
Complications of herpes zoster – post-herpetic neuralgia.
Other complications of herpes zoster.
Recurrence of herpes zoster.
Hope-Simpson’s theory on the pathogenesis of herpes zoster
Herpes zoster and stroke risk
Theory of herpes zoster pathogenesis illustrated
VZV and herpes zoster prevalence
Herpes zoster incidence rates.
Incidence of herpes zoster is similar across Europe.
Effect of age and gender on incidence of herpes zoster
Focus on LATAM region
Economic burden of herpes zoster (1)
Economic burden of herpes zoster (2)
Medical management of herpes zoster in immunocompetent people – antiviral therapy
Medical management of herpes zoster in immunocompetent people – supplementary therapy.
Medical management of herpes zoster in immunocompromised patients and special groups
Herpes zoster vaccine – current product Zostavax
Rationale for vaccination against herpes zoster
Zostavax – formulation and development.
The Shingles Prevention Study – design and efficacy
Shingles Prevention Study – long-term efficacy of Zostavax and immunology.
Zostavax in people aged 50–59 years: ZEST study.
Safety of Zostavax
Licensing history of Zostavax
Cost-effectiveness of Zostavax
Recommendations for herpes zoster vaccination.
Zostavax uptake
Reasons for poor uptake of Zostavax
Zostavax sales data – Merck & Co.
Zostavax and the UK
Herpes zoster vaccine – overview of current R&D
Rationale to develop improved herpes zoster vaccines
V212 (ZVHT): a heat-treated zoster vaccine
HZ/su (GSK1437173A): a developmental vaccine from GlaxoSmithKline
Phase III studies of HZ/su (GSK1437173A) in general population
Phase III studies of HZ/su (GSK1437173A) in special populations
New Herpes zoster vaccine: commercial considerations
New Herpes zoster vaccine: target product profile
Assumptions on future licensing of zoster vaccines
Assumptions on the future of the zoster vaccine market
Disclaimer
[Contents – Vaccine demand model(s) (MS Excel-based) – 2 models (HI/LO scenarios)]
WORKSHEETS: ~50
Title sheet
Charts – Total Vol and Val
Charts – Vol and Val by population
Charts – Vol and Val by country
Charts – market share
Vol and Val vaccine and pop
Vol val by country
Vol and val general younger
Vol and val immunocompromised
USA >60 yrs
USA 50-59 yrs
USA >60 yrs immunocompromised
CANADA >60 yrs
CANADA 50-59 yrs
CANADA >60 yrs immunocompromised
FRANCE >60 yrs
FRANCE 50-59 yrs
FRANCE >60 yrs immunocompromised
UNITED KINGDOM >60 yrs
UNITED KINGDOM 50-59 yrs
UNITED KINGDOM >60 yrs immunocompromised
GERMANY >60 yrs
GERMANY 50-59 yrs
GERMANY >60 yrs immunocompromised
ITALY >60 yrs
ITALY 50-59 yrs
ITALY >60 yrs immunocompromised
SPAIN >60 yrs
SPAIN 50-59 yrs
SPAIN >60 yrs immunocompromised
BRAZIL >60 yrs
BRAZIL 50-59 yrs
BRAZIL >60 yrs immunocompromised
ARGENTINA >60 yrs
ARGENTINA 50-59 yrs
ARGENTINA >60 yrs immunocompromised
MEXICO >60 yrs
MEXICO 50-59 yrs
MEXICO >60 yrs immunocompromised
Populations
【レポート販売概要】
■ タイトル：帯状疱疹ワクチン（Herpes Zoster vaccine）の世界市場機会分析■ 英文：MarketVIEW: Herpes Zoster (adult) vaccines
Global vaccine commercial opportunity assessment
■ 発行日：2014年10月
■ 調査会社：VacZine Analytics
■ 商品コード：VAMV054-2014
■ 調査対象地域：グローバル
- ゲラニオールの世界市場2015Geraniol (CAS 106-24-1) Market Research Report 2015 aims at providing comprehensive data on Geraniol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Geraniol description, covers its application areas, manufacturing methods, patterns. It captures Geraniol market trends, pays close attention to Geraniol manufacturers and names suppliers. Besides, …
- Tokyo Gas Co., Ltd.：石油・ガスバリューチェーン分析レポート2013Tokyo Gas Co., Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Tokyo Gas Co., Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Tokyo Gas Co., Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 世界のポリカーボネート樹脂市場動向及び予測（～2018）Polycarbonate is a dominant engineering plastic. It also upholds the image of commodity plastics due to the high consumption and its applicability in a varied range of industries. The PC market experiences strong growth that is expected to get robust in the future. This growth is due to its tremendous physical properties that make it an efficient replacement for traditional plastics and other mate …
- モバイルバーコードマーケティング：課題、機会、世界展望（Mobile Bar Code Marketing: Challenges, Opportunities, Global Outlook 2012-2017）Mobile Barcodes are now appearing in various media including magazines, catalogs, website, outdoor signage and billboards, packaged goods, conference presentations, name tags, clothing, and more. With the increasing adoption of smartphones, and rapid advancements in their capabilities, Mobile Barcodes are becoming a powerful advertising vehicle. Unfortunately, far too few marketers recognize its t …
- 消防車の世界市場分析：用途別（住宅、商業、企業・空港、軍用）、地域別（北アメリカ、中国、ヨーロッパ、中東、アフリカ、アジア太平洋、その他の地域）、セグメント予測、2011 – 2024The global fire trucks market is projected to reach USD 7.41 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for fire trucks owing to rising penetration in application segments, including residential & commercial, enterprises & airports, and military, is expected to drive market growth over the forecast period. Growing infrastructure in the developing countri …
- 家庭用エアコンの世界市場2015-2019About residential air conditioner A residential air conditioner is deployed to lower the air temperature of a room, maintain suitable humidity, provide ventilation, and keep the air free from dust, soot, and micro-organisms. It employs the refrigerant cycle to transport heat outside the room. The main components of the air conditioner are: • Compressor • Condenser • Metering device • Cooling coil …
- Daleco Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- 2012Daleco Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Daleco Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 世界のスマートグリッド・サイバーセキュリティー市場動向（2012-2016）TechNavio's analysts forecast the Global Smart Grid Cyber Security market to grow at a CAGR of 29.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the occurrence of cyber threats which in turn is forcing the implementation of strong security measures. The Global Smart Grid Cyber Security Systems market has also been witnessing an in …
- Hemostasis：グローバル臨床試験レビューH2, 2013Hemostasis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H2, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- Celiac Disease：グローバル臨床試験レビューH2, 2013Celiac Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, H2, 2013" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per …
- クラウドセキュリティの世界市場：クラウドIAM、クラウドEメールセキュリティ、クラウドIDS/IPS、クラウドDLPAbout Cloud Security A cloud security solution is a stand-alone solution or a suite of products that provides security to cloud-based services or cloud computing architectures. A typical cloud security solution offers features like encryption, IAM, endpoint monitoring, vulnerability scanning, intrusion detection, and application and messaging security. It helps protect cloud content from unauthori …
- 軍用航空機向け情報・監視・偵察（ISR）技術の世界市場2016-2026This brand new report from business intelligence provider visiongain offers thorough analysis of the global military airborne ISR market and future prospects. Visiongain assesses that the airborne ISR market will generate revenues of $26,672m in 2016. Now: “Finmeccanica to Supply Angola with Maritime Surveillance Equipment, Craft”. This is one example of the business relevant headline that you nee …
- スティックPCの世界市場2016-2020About Stick PCs Stick PCs come with an operating system. The most popular operating systems in the stick PC market are Windows 8.1 and Windows 10. There are stick PCs with dual operating systems as well where they can switch between the operating systems, according to their requirement. MagicStick is one such vendor that provides dual OSs. There are also stick PCs without OSs where the user is giv …
- 心臓発作：治療薬のグローバル治験動向（2014年下半期）Heart Attack Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 肥満：現在及び未来の競争環境分析PharmaPoint: Obesity - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Obesity - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing obesity market. The report identifies and analyses the key companies shaping and driving the global obesity market. The report p …
